Fanconi's anemia and malignancies - PubMed (original) (raw)
Review
Fanconi's anemia and malignancies
B P Alter. Am J Hematol. 1996 Oct.
Free article
Abstract
Patients with Fanconi's anemia (FA) are at a high risk for development of malignancies. It is well-known that leukemia occurs in approximately 10% of cases, with increasing risk with age. Less commonly recognized is the risk for myelodysplastic syndromes (approximately 5%); the relationship between myelodysplasia and evolution to leukemia remains speculative. What also needs to be emphasized is that older patients have an ever-increasing risk for development of solid tumors, with at least 5% reported to have liver tumors (male:female ratio, 2:1) and an equal number of other cancers (female:male ratio, 3:1, even after exclusion of gynecologic malignancies). Hematologists have tended to focus on aplastic anemia and leukemia. As FA patients live longer, more of the other malignancies will occur, perhaps related to cord blood or bone marrow transplant, or treatment with cytokines. This review identifies the types of tumors for which patients with Fanconi's anemia are at risk.
Similar articles
- Cancer in Fanconi anemia, 1927-2001.
Alter BP. Alter BP. Cancer. 2003 Jan 15;97(2):425-40. doi: 10.1002/cncr.11046. Cancer. 2003. PMID: 12518367 Review. - Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions.
Velazquez I, Alter BP. Velazquez I, et al. Am J Hematol. 2004 Nov;77(3):257-67. doi: 10.1002/ajh.20183. Am J Hematol. 2004. PMID: 15495253 Review. - Fanconi's anemia, transplantation, and cancer.
Alter BP. Alter BP. Pediatr Transplant. 2005 Dec;9 Suppl 7:81-6. doi: 10.1111/j.1399-3046.2005.00440.x. Pediatr Transplant. 2005. PMID: 16305622 - Fanconi's anemia. Current concepts.
Alter BP. Alter BP. Am J Pediatr Hematol Oncol. 1992 May;14(2):170-6. Am J Pediatr Hematol Oncol. 1992. PMID: 1530123 Review. - [Acute leukemia in Fanconi's anemia. Report of a patient and review of the literature].
van Gils JE, Mandel C, van Weel-Sipman MH, de Koning J, van 't Veer-Korthof ET. van Gils JE, et al. Tijdschr Kindergeneeskd. 1987 Apr;55(2):68-72. Tijdschr Kindergeneeskd. 1987. PMID: 3590139 Dutch.
Cited by
- Fanconi Anemia: A Rare Genetic Disorder.
Thakur B, Hiwale KM. Thakur B, et al. Cureus. 2023 May 11;15(5):e38899. doi: 10.7759/cureus.38899. eCollection 2023 May. Cureus. 2023. PMID: 37303314 Free PMC article. - Cytogenetics in Fanconi Anemia: The Importance of Follow-Up and the Search for New Biomarkers of Genomic Instability.
Merfort LW, Lisboa MO, Cavalli LR, Bonfim CMS. Merfort LW, et al. Int J Mol Sci. 2022 Nov 15;23(22):14119. doi: 10.3390/ijms232214119. Int J Mol Sci. 2022. PMID: 36430597 Free PMC article. Review. - A Narrative Review on Fanconi Anemia: Genetic and Diagnostic Considerations.
Sharma P, Sharma N, Sharma D. Sharma P, et al. Glob Med Genet. 2022 Sep 5;9(3):237-241. doi: 10.1055/s-0042-1751303. eCollection 2022 Sep. Glob Med Genet. 2022. PMID: 36071913 Free PMC article. Review. - FANCL supports Parkin-mediated mitophagy in a ubiquitin ligase-independent manner.
Beesetti S, Sirasanagandla S, Sakurada SM, Pruett-Miller SM, Sumpter R Jr, Levine B, Potts MB. Beesetti S, et al. Biochim Biophys Acta Mol Basis Dis. 2022 Sep 1;1868(9):166453. doi: 10.1016/j.bbadis.2022.166453. Epub 2022 May 26. Biochim Biophys Acta Mol Basis Dis. 2022. PMID: 35644338 Free PMC article. - Head and Neck Cancer Susceptibility and Metabolism in Fanconi Anemia.
Chihanga T, Vicente-Muñoz S, Ruiz-Torres S, Pal B, Sertorio M, Andreassen PR, Khoury R, Mehta P, Davies SM, Lane AN, Romick-Rosendale LE, Wells SI. Chihanga T, et al. Cancers (Basel). 2022 Apr 18;14(8):2040. doi: 10.3390/cancers14082040. Cancers (Basel). 2022. PMID: 35454946 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials